Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”

Author

Shazly, Gamal A.

Source

BioMed Research International

Issue

Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-1, 1 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2017-08-13

Country of Publication

Egypt

No. of Pages

1

Main Subjects

Medicine

Abstract EN

In the article titled “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment” [1], there was an error in Acknowledgments, which should be corrected as follows.

American Psychological Association (APA)

Shazly, Gamal A.. 2017. Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”. BioMed Research International،Vol. 2017, no. 2017, pp.1-1.
https://search.emarefa.net/detail/BIM-1138209

Modern Language Association (MLA)

Shazly, Gamal A.. Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”. BioMed Research International No. 2017 (2017), pp.1-1.
https://search.emarefa.net/detail/BIM-1138209

American Medical Association (AMA)

Shazly, Gamal A.. Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”. BioMed Research International. 2017. Vol. 2017, no. 2017, pp.1-1.
https://search.emarefa.net/detail/BIM-1138209

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1138209